 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$7.87 |
$7.99 |
$7.40 |
$7.52 |
624.00K | | 04/15/2024 |
$1.85 |
$1.95 |
$1.25 |
$1.30 |
35.57M | | 04/16/2024 |
$1.32 |
$1.65 |
$1.11 |
$1.20 |
22.20M | | 04/17/2024 |
$1.23 |
$1.54 |
$1.16 |
$1.44 |
10.37M | | 04/18/2024 |
$1.46 |
$1.53 |
$1.17 |
$1.41 |
4.84M |
|
|
| Marinus Pharmaceuticals is a pharmaceutical company focused on the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus. The U.S Food and Drug Administration approved the use of ZTALMY (ganaxolone) oral suspension for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder in patients two years of age and older. Co. is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral. Ganaxolone is a synthetic analog of allopregnanolone, an endogenous neurosteroid. | |
|
Marinus Pharmaceuticals (MRNS) has the following price history information. Looking back at MRNS historical stock prices for the last five trading days, on April 12, 2024, MRNS opened at $7.87, traded as high as $7.99 and as low as $7.40, and closed at $7.52. Trading volume was a total of 624.00K shares. On April 15, 2024, MRNS opened at $1.85, traded as high as $1.95 and as low as $1.25, and closed at $1.30. Trading volume was a total of 35.57M shares. On April 16, 2024, MRNS opened at $1.32, traded as high as $1.65 and as low as $1.11, and closed at $1.20. Trading volume was a total of 22.20M shares. On April 17, 2024, MRNS opened at $1.23, traded as high as $1.54 and as low as $1.16, and closed at $1.44. Trading volume was a total of 10.37M shares. On April 18, 2024, MRNS opened at $1.46, traded as high as $1.53 and as low as $1.17, and closed at $1.41. Trading volume was a total of 4.84M shares.
MRNS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Marinus Pharmaceuticals shares, starting with a $10,000 purchase of MRNS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/01/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$32.00 |
|
| End price/share: |
$1.41 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.59% |
|
| Average Annual Total Return: |
-27.47% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$440.71 |
|
| Years: |
9.72 |
|
|
|
| Date |
Close |
| 04/12/2024 | $7.52 | | 04/15/2024 | $1.30 | | 04/16/2024 | $1.20 | | 04/17/2024 | $1.44 | | 04/18/2024 | $1.41 |
|
|
Free MRNS Email Alerts:
